148 related articles for article (PubMed ID: 12895696)
1. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
[TBL] [Abstract][Full Text] [Related]
2. Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities.
Liu H; Geng M; Xin X; Li F; Zhang Z; Li J; Ding J
Glycobiology; 2005 May; 15(5):501-10. PubMed ID: 15616125
[TBL] [Abstract][Full Text] [Related]
3. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding.
Harrop HA; Coombe DR; Rider CC
AIDS; 1994 Feb; 8(2):183-92. PubMed ID: 8043225
[TBL] [Abstract][Full Text] [Related]
4. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes.
Miao B; Geng M; Li J; Li F; Chen H; Guan H; Ding J
Biochem Pharmacol; 2004 Aug; 68(4):641-9. PubMed ID: 15276071
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
[TBL] [Abstract][Full Text] [Related]
6. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
Callahan LN; Phelan M; Mallinson M; Norcross MA
J Virol; 1991 Mar; 65(3):1543-50. PubMed ID: 1995952
[TBL] [Abstract][Full Text] [Related]
7. Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad.
Wu YL; Ai J; Zhao JM; Xiong B; Xin XJ; Geng MY; Xin XL; Jiang HD
Acta Pharmacol Sin; 2011 May; 32(5):647-54. PubMed ID: 21499289
[TBL] [Abstract][Full Text] [Related]
8. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
Ho HT; Fan L; Nowicka-Sans B; McAuliffe B; Li CB; Yamanaka G; Zhou N; Fang H; Dicker I; Dalterio R; Gong YF; Wang T; Yin Z; Ueda Y; Matiskella J; Kadow J; Clapham P; Robinson J; Colonno R; Lin PF
J Virol; 2006 Apr; 80(8):4017-25. PubMed ID: 16571818
[TBL] [Abstract][Full Text] [Related]
9. Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
AIDS; 1992 Mar; 6(3):249-56. PubMed ID: 1348943
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120.
Ferrer M; Sullivan BJ; Godbout KL; Burke E; Stump HS; Godoy J; Golden A; Profy AT; van Schravendijk MR
J Pept Res; 1999 Jul; 54(1):32-42. PubMed ID: 10448968
[TBL] [Abstract][Full Text] [Related]
11. Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct.
Lederman S; Bergmann JE; Cleary AM; Yellin MJ; Fusco PJ; Chess L
AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1599-610. PubMed ID: 1457206
[TBL] [Abstract][Full Text] [Related]
12. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
13. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of T cell function by a marine algae-derived sulfated polymannuroguluronate: in vitro analysis of novel mechanisms.
Xia W; Li J; Geng M; Xin X; Ding J
J Pharmacol Sci; 2005 Jan; 97(1):107-15. PubMed ID: 15665445
[TBL] [Abstract][Full Text] [Related]
15. Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific.
Ashish ; Juncadella IJ; Garg R; Boone CD; Anguita J; Krueger JK
J Biol Chem; 2008 Feb; 283(5):2761-72. PubMed ID: 18045872
[TBL] [Abstract][Full Text] [Related]
16. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.
Corbeau P; Haran M; Binz H; Devaux C
Mol Immunol; 1994 Jun; 31(8):569-75. PubMed ID: 8196669
[TBL] [Abstract][Full Text] [Related]
17. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
[TBL] [Abstract][Full Text] [Related]
18. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
